QUANTITATION OF DIDANOSINE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引：56

作者：

KNUPP, CA

STANCATO, FA

PAPP, EA

BARBHAIYA, RH

机构：

[1] Department of Metabolism and Pharmacokinetics, Pharmaceutical Research and Development Division, Bristol-Myers Squibb Company, Syracuse

来源：

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1990年 / 533卷

关键词：

D O I：

10.1016/S0378-4347(00)82215-X

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

[No abstract available]

引用

页码：282 / 290

页数：9

共 11 条

[1] PREFORMULATION SOLUBILITY AND KINETIC-STUDIES OF 2',3'-DIDEOXYPURINE NUCLEOSIDES - POTENTIAL ANTI-AIDS AGENTS [J].

ANDERSON, BD ;

WYGANT, MB ;

XIANG, TX ;

WAUGH, WA ;

STELLA, VJ .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 45 (1-2) :27-37

[2] APPLICATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND THERMOSPRAY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY TO THE ANALYSIS AND IDENTIFICATION OF 2',3'-DIDEOXYADENOSINE AND ITS METABOLITE IN BIOLOGICAL MEDIA [J].

BLAU, PA ;

HINES, JW ;

VOYKSNER, RD .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 420 (01) :1-12

[3]

ELDAREER SM, 1989, INVEST NEW DRUG, V7, P139

[4]

FARMEN RH, 1987, DRUG INF J, V21, P141

[5] DETERMINATION OF 2',3'-DIDEOXYADENOSINE, 2',3'-DIDEOXYINOSINE AND 2',3'-DIDEOXYCYTIDINE IN BIOLOGICAL SAMPLES [J].

KALIN, JR ;

HILL, DL .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 431 (01) :184-191

[6] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 3'-AZIDO-3'-DEOXYTHYMIDINE - A NOVEL PYRIMIDINE ANALOG WITH POTENTIAL APPLICATION FOR THE TREATMENT OF PATIENTS WITH AIDS AND RELATED DISEASES [J].

KLECKER, RW ;

COLLINS, JM ;

YARCHOAN, R ;

THOMAS, R ;

JENKINS, JF ;

BRODER, S ;

MYERS, CE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :407-412

[7] DISINFECTION AND INACTIVATION OF THE HUMAN T-LYMPHOTROPIC VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS [J].

MARTIN, LS ;

MCDOUGAL, JS ;

LOSKOSKI, SL .

JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) :400-403

[8] INHIBITION OF THE INVITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPHIC-T VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) BY 2',3'-DIDEOXYNUCLEOSIDES [J].

MITSUYA, H ;

BRODER, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1911-1915

[9]

RAY G, 1987, ANAL LETT, V20, P1815

[10] STABILITY AND INACTIVATION OF HTLV-III LAV UNDER CLINICAL AND LABORATORY ENVIRONMENTS [J].

RESNICK, L ;

VEREN, K ;

SALAHUDDIN, SZ ;

TONDREAU, S ;

MARKHAM, PD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (14) :1887-1891

← 1 2 →